从络病角度分析阿尔茨海默病发病机制及治疗
Analysis of the Pathogenesis and Treatment of Alzheimer’s Disease from the Perspective of Collateral Disease
摘要: 阿尔茨海默病(AD)在世界范围内发病率高,并持续增长,中国是世界上AD患者最多的国家,也是发病患者数量增长最快的国家。中医可以改善AD患者症状,提升临床综合疗效。络病理论是中医理论的重要组成部分。本文通过阅读古籍和现代文献,分析AD发病与络脉亏虚,络脉淤堵,毒损脑络,而后产生的一系列病理变化有关。现代学者气脉和血脉理论的提出,丰富了AD的络病发病机制理论。本文通过对AD络脉发病机制研究,以期为临床AD的综合康复方案中的中医治疗提供思路。
Abstract: Alzheimer’s Disease (AD) has a high incidence rate worldwide and continues to grow. China has the largest number of AD patients in the world and is also the country with the fastest-growing number of affected patients. Traditional Chinese medicine can improve the symptoms of AD patients and enhance the comprehensive clinical efficacy. The collateral disease theory is an important part of traditional Chinese medicine theory. By reading ancient books and modern literature, this paper analyzes that the pathogenesis of AD is related to a series of pathological changes caused by collateral deficiency, collateral stasis, and toxic damage to brain collaterals. The proposal of the theories of Qi collaterals and blood collaterals by modern scholars has enriched the theory of the pathogenesis of collateral diseases in AD. Through the study on the pathogenesis of AD collaterals, this paper aims to provide ideas for traditional Chinese medicine treatment in the comprehensive rehabilitation program of clinical AD.
文章引用:李泓仪, 邓忠淇, 郑晖. 从络病角度分析阿尔茨海默病发病机制及治疗[J]. 中医学, 2025, 14(11): 4807-4813. https://doi.org/10.12677/tcm.2025.1411693

参考文献

[1] Jack, C.R., Bennett, D.A., Blennow, K., Carrillo, M.C., Dunn, B., Haeberlein, S.B., et al. (2018) NIA‐AA Research Framework: Toward a Biological Definition of Alzheimer’s Disease. Alzheimers & Dementia, 14, 535-562. [Google Scholar] [CrossRef] [PubMed]
[2] 首都医科大学宣武医院国家神经疾病医学中心, 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 国家卫生健康委能力建设和继续教育中心, 中国人口与发展研究中心, 《中国阿尔茨海默病蓝皮书》项目组. 中国阿尔茨海默病蓝皮书(精简版) [J]. 中华医学杂志, 2024, 104(29): 2701-2727.
[3] Jia, L., Du, Y., Chu, L., Zhang, Z., Li, F., Lyu, D., et al. (2020) Prevalence, Risk Factors, and Management of Dementia and Mild Cognitive Impairment in Adults Aged 60 Years or Older in China: A Cross-Sectional Study. The Lancet Public Health, 5, e661-e671. [Google Scholar] [CrossRef] [PubMed]
[4] Mattap, S.M., Mohan, D., McGrattan, A.M., Allotey, P., Stephan, B.C., Reidpath, D.D., et al. (2022) The Economic Burden of Dementia in Low-and Middle-Income Countries (LMICs): A Systematic Review. BMJ Global Health, 7, e007409. [Google Scholar] [CrossRef] [PubMed]
[5] Jia, J., Wei, C., Chen, S., Li, F., Tang, Y., Qin, W., et al. (2018) The Cost of Alzheimer’s Disease in China and Re‐estimation of Costs Worldwide. Alzheimers & Dementia, 14, 483-491. [Google Scholar] [CrossRef] [PubMed]
[6] 时晶, 倪敬年, 田金洲, 等. 清热解毒法治疗阿尔茨海默病的系统评价[J]. 北京中医药大学学报, 2019, 42(8): 667-672.
[7] 苏芮, 韩振蕴, 范吉平, 等. “毒损脑络”理论在阿尔茨海默病中医研究领域中的意义[J]. 中医杂志, 2011, 52(16): 1370-1371.
[8] 吴珊, 胡镜清, 王传池, 等. 从“火(热)”病机论治老年性痴呆[J]. 世界科学技术中医药现代化, 2019, 21(10): 2017-2020.
[9] 于苗, 丁薇, 王悦, 等. 从“络损髓伤”探讨脑小血管病的病机[J]. 中医药导报, 2023, 29(9): 134-136, 164.
[10] 田雨沐, 潘菊华. 基于肾虚-痰瘀互结-毒损脑络病机探讨脑小血管病[J]. 中西医结合心脑血管病杂志, 2023, 21(8): 1525-1529.
[11] 田金洲, 解恒革, 王鲁宁, 等. 中国阿尔茨海默病痴呆诊疗指南(2020年版) [J]. 中华老年医学杂志, 2021, 40(3): 269-283.
[12] Liu, S., Chang, L. and Wei, C. (2019) The Sonic Hedgehog Pathway Mediates Tongxinluo Capsule‐induced Protection against Blood‐brain Barrier Disruption after Ischaemic Stroke in Mice. Basic & Clinical Pharmacology & Toxicology, 124, 660-669. [Google Scholar] [CrossRef] [PubMed]
[13] 黄渤皓, 赵永烈, 孙治琪, 刘晨笑, 赵凡莹, 刘子旺. 电针“百会”“肾俞”对淀粉样前体蛋白/早老蛋白1转基因小鼠认知功能和神经炎症的影响[J]. 世界中医药, 2023, 18(4): 468-472.
[14] 倪芳英, 李丽萍. 五脏俞麦粒灸治疗无痴呆型血管性认知障碍临床观察[J]. 上海针灸杂志, 2018, 37(2): 174-178.